News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Candel Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its lead adenovirus asset CAN-2409, for the treatment of pancreatic cancer.
South Korea has issued guidelines to monitor the side effects of the two approved CAR-T therapies – Kymriah from Novartis and Carvykti from Janssen.
UK-based Lindus Health and US-based Thirty Madison today (December 14) announced they have completed the enrolment of a trial to assess their personalized dermatology telemedicine platform, Facet.